Technical Evaluation of Commercial IMUs Within Clinical Gait Analysis
Technical Evaluation of Commercial IMUs Within Clinical Gait Analysis in Adult Patients With Neurological Disorders
Roessingh Research and Development
40 participants
Jan 25, 2023
OBSERVATIONAL
Conditions
Summary
A standard clinical gait analysis consists of observing walking with video (2D) or advanced equipment (VICON 3D). This 3D method provides detailed information about the gait pattern, but is time-consuming in implementation and data analysis. There are commercial 3D systems on the market that are used in healthy individuals and in sports. These so-called Inertial Measurement Units (IMUs) may also be suitable for use in the clinic. In this research protocol, the aim is to test the usability of commercial sensors and technically compare them with standard clinical 3D gait analysis in adult patients with a neurological disorder.
Eligibility
Inclusion Criteria5
- Subjects referred for clinical gait analysis at Roessingh Centre for Rehabilition in Enschede, the Netherlands:
- Disorders affecting walking, including amongst others stroke, traumatic brain injury, MS, incomplete spinal cord injury, CP, Spina Bifida, neuromuscular diseases
- age minimum 18 years
- Viosca score minimum 2; meaning minimal independent walking ability indoors
- increased fall risk or increased effort of walking because of: 1) decreased stability during stance; and/or 2) decreased foot clearance during swing; and/or 3) not able to walk on bare feet because of equinovarus; and/or 4) fatigue during walking because of compansatory strategies.
Exclusion Criteria2
- subjects referred for clinical gait analysis because of problems other than stiff knee gait or foot surgery
- severe deficits in communication, memory and understanding at such a level that it would affect instructions during the measurements
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Subjects are measured using Vicon 3D analysis, combined with IMU-sensors
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05751408